NASDAQ · OKYO
OKYO Pharma Limited
$1.50+$0.01 (+0.67%)
OKYO Pharma Limited’s quoted price sits in the lower half of its reported 52-week range, 53.13% below the high.
Loading market information…
OTC · CHBRF · USD
Stock price, earnings
Quote as of Jan 24, 2025, 12:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Chill Brands Group PLC’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Chill Brands Group PLC’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Chill Brands Group PLC, a London-based company founded in 2014, specializes in the comprehensive process of bringing consumer products to market – from initial research and development through to manufacturing and distribution. The firm's offerings primarily consist of cannabidiol (CBD) consumer items and a broader array of lifestyle goods, which are sold under the Chill.com and Zoetic brands. Geographically, its operations span the United States, the United Kingdom, and the wider European continent. The product range includes tobacco alternatives, such as smokes and chewable pouches, as well as various wellness and personal care items like oral tinctures, soft-gel capsules, massage oils, and topical cosmetic solutions. The company formally adopted the name Chill Brands Group PLC in August 2021, having previously been known as Zoetic International Plc.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 12:27 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$1.50+$0.01 (+0.67%)
OKYO Pharma Limited’s quoted price sits in the lower half of its reported 52-week range, 53.13% below the high.
¥57-¥1 (-1.72%)
Kubota Pharmaceutical Holdings Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 83.71% below the high.
$0.03+$0.00 (+2.04%)
Hempstract, Inc.’s quoted price sits in the upper half of its reported 52-week range, 33.04% below the high.
$0.22$0.00 (0.0%)
Generation Hemp, Inc.’s quoted price sits in the lower half of its reported 52-week range, 62.7% below the high.
$0.08$0.00 (0.0%)
Renalytix Plc’s quoted price sits in the lower half of its reported 52-week range, 87.52% below the high.
€0.10-€0.00 (-0.73%)
Mauna Kea Technologies S.A.’s quoted price sits in the lower half of its reported 52-week range, 58.66% below the high.
$0.15-$0.01 (-8.96%)
Vinergy Capital Inc.’s quoted price sits in the upper half of its reported 52-week range, 48.39% below the high.
$0.16-$0.03 (-15.36%)
TPCO Holding Corp.’s quoted price sits in the lower half of its reported 52-week range, 83.81% below the high.
